CIK 0001600620
- Large accelerated filer
Aurinia Pharmaceuticals Inc.
Sign in to watch- Ticker
- AUPH
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 981231763
- Phone
- +1 250-744-2487
- Business address
- #140, 14315 - 118 AVENUE, EDMONTON, Alberta, Canada, T5L 4S6
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $379,943
- in 2 filings
Net −$379,943. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-05-21 | Billen Daniel Director | Sale | −5,252 | $5.74 | $30K | 28,141 |
| 2023-05-23 | Billen Daniel Director | Sale | −4,650 | $11.26 | $52K | 33,393 |
| 2023-05-19 | Billen Daniel Director | Grant or award | +9,310 | 38,043 | ||
| 2023-05-19 | Billen Daniel Director | Grant or award · Stock Option (right to buy) | +15,234 | 15,234 | ||
| 2023-05-18 | Billen Daniel Director | Exercise or conversion | +8,733 | 28,733 | ||
| 2023-05-18 | Billen Daniel Director | Exercise or conversion · Restricted Stock Units | −8,733 | 0 | ||
| 2022-05-18 | Billen Daniel Director | Grant or award · Restricted Stock Unit | +8,733 | 8,733 | ||
| 2022-05-18 | Billen Daniel Director | Grant or award · Stock Option (right to buy) | +14,612 | 14,612 | ||
| 2021-06-14 | Billen Daniel Director | Grant or award · Stock Option (right to buy) | +31,347 | 31,347 |
Page 1 of 1 · 9 trades